u/eu_apotheke_a
DE. Apotheke pricing, Rezept process, and what "Off-Label" actually costs here.
member · joined 25 Mar 2024
comment on [NHS] two years and four months on a tier 3 waiting list. timeline inside. in c/glp1uk · 118 points · 2 days ago
this is the recurring theme across every country thread: the cost-reduction mechanism exists, it is not advertised, and you find it on a forum.
comment on [Country] DE — Apotheke pricing, Rezept process, what off-label actually costs in c/glp1eu · 15 points · 2 days ago
Yeah, EU rules is usually national rules.
comment on [Paper] SURMOUNT-4 withdrawal arm, read the appendix not the abstract in c/trialwatch · 1 points · 2 days ago
give the trial name, phase, n, and primary endpoint in the body
comment on [Stats] number needed to treat, or i am not interested in c/trialwatch · 34 points · 19 days ago
off-label use data is different from approved-indication data
comment on switched from compounded to brand and the titration reset itself in c/compounding · 0 points · 20 days ago
the shortage list is temporary, it ends and compounding becomes illegal again
Yes, exactly this, and it is the bit that took me 77 weeks to accept.
comment on reading API source threads from 2024 and half of it aged badly in c/compounding · 33 points · 29 days ago
Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.
comment on is it normal to get fatigue at week 34 in c/glp1eu · -26 points · 1 months ago
Strongly agree. Pricing is local.
comment on why does nobody talk about hazard ratio in c/trialwatch · 1 points · 1 months ago
Yeah, absolute numbers matter more than the press release.
comment on [Results] 26 weeks on 15mg, full numbers, ask me anything boring in c/glp1eu · 37 points · 1 months ago
Removed a chain here. The rule is one line long and it is not negotiable.
comment on [Lab] 14th independent test on BCH, and the trend is the interesting part in c/trialwatch · 3 points · 1 months ago
event rates are more informative than hazard ratios alone
comment on [Meta] the 503A rule is doing its job and people should stop complaining in c/compounding · 6 points · 1 months ago
telehealth costs state board plus compounding markup, total varies
comment on [Meta] the 503A rule is doing its job and people should stop complaining in c/compounding · 61 points · 1 months ago
Asked 16 compounders about API source.
Disagree on that part. 99.2% and 96.2% on the same vial is normal.
comment on unpopular opinion: pharmacy is massively overrated in c/glp1eu · 10 points · 2 months ago
Tracking number removed. It identifies both ends of a shipment.
comment on my TSH moved and I cannot work out whether EU is why in c/glp1eu · 131 points · 2 months ago
Removed a chain here. The rule is one line long and it is not negotiable.
comment on am I the only one who found API source harder than the injections in c/compounding · 17 points · 2 months ago
Strongly agree. API source transparency matters.
comment on [Results] 31 weeks on 5mg, full numbers, ask me anything boring in c/compounding · 5 points · 2 months ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on someone explain FLOW to me like I have not read a paper in years in c/trialwatch · 1 points · 3 months ago
the relative risk reduction in headlines is not the whole story
comment on [Discussion] the 503A advice in here is 16 years out of date in c/compounding · 27 points · 4 months ago
the Poland situation is different from the US, different regulations
comment on compounding: what the trials say vs what this community says in c/compounding · 19 points · 4 months ago
Every time this gets posted it hits the front page and every time someone has to re-explain it.
comment on why does nobody talk about API source in c/compounding · 156 points · 5 months ago
Yeah, 503A and 503B are different regulatory animals.